![]() |
市場調查報告書
商品編碼
1887037
眼科超音波市場規模、佔有率、成長及全球產業分析:依類型、應用和地區劃分的洞察,以及2024年至2032年的預測Ophthalmic Ultrasound Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032 |
||||||
由於眼部疾病的增加、技術創新以及先進眼科診斷設備的引入,全球眼科超音波市場持續穩定成長。據報道,該市場規模在2024年達到2.839億美元,2025年成長至3.037億美元,到2032年將達4.996億美元。這意味著2025年至2032年期間的複合年增長率高達7.4%,證實了市場對眼科影像技術的長期持續需求。
眼科超音波設備可幫助眼科醫師觀察眼內結構,包括視網膜、眼眶、玻璃體和眼前節。這些影像工具在診斷青光眼、糖尿病視網膜病變、玻璃體出血、腫瘤和外傷相關眼部併發症方面發揮著至關重要的作用。遠視、白內障和青光眼在全球的發病率不斷上升,推動了對精準診斷設備的需求。例如,Crystal Vision Ltd. 估計,到 2025 年底,全球 30.6% 的成年人將患有遠視,這凸顯了早期檢測技術的必要性。
北美將在 2024 年保持領先地位,市佔率達 42.40%
北美在 2024 年以 42.40% 的市佔率引領全球市場,創造了 1.204 億美元的收入。該地區的領先地位歸功於先進的醫療基礎設施、成像工具在臨床環境中的廣泛應用以及各種眼部患者病率的不斷上升。根據美國疾病管制與預防中心 (CDC) 2024 年的數據,美國有 420 萬人患有青光眼,其中 150 萬人患有影響視力的青光眼。如此高的疾病負擔推動了臨床對眼科診斷設備的需求。 Micro Medical Devices (MMD)、Keeler 和 Nidek 等公司積極參與醫療展覽和會議,也有助於提高人們對眼科疾病的認識,並促進其產品的普及應用。
市場驅動因素:眼科疾病負擔日益加重
全球遠視、青光眼、老年黃斑部病變 (AMD) 和糖尿病視網膜病變的發生率持續上升,因此迫切需要能夠早期檢測的眼科超音波系統。根據Crystal Vision Ltd.預測,到2025年底,遠視將影響37.2%的美國成年人和23.1%的歐洲成年人。這些疾病的診斷和手術方案製定都需要精準的影像檢查,而眼科超音波設備仍是有效疾病管理的關鍵工具。
市場限制因素:高成本與替代技術的湧現
儘管需求不斷增長,但眼科超音波系統的普及受到設備成本高昂的限制,其價格通常在5,500美元到20,000美元之間。這限制了低收入地區和小型醫療機構對這些設備的使用。此外,由於其先進的診斷能力,臨床醫生越來越傾向於使用其他先進的影像技術(如光學相干斷層掃描(OCT)、眼底成像、磁振造影(MRI)等)。新型OCT設備的出現,例如NIDEK公司於2024年6月發布的RS-1青光眼OCT設備,正在加劇傳統超音波設備的競爭壓力。
機會:醫療基礎設施的擴展
全球眼科診所、眼科醫院和專業診斷中心的不斷湧現,帶來了新的市場機會。例如,雪梨眼科醫院的 Gadigal 眼科診所於 2024 年 10 月開業,提升了澳洲的診斷能力。諸如 LVPEI 於 2025 年 3 月舉辦的 "青光眼宣傳週" 等眼部保健宣傳活動,進一步促進了早期篩檢,並支撐了對診斷超音波設備的需求。
技術趨勢:便攜式 3D 超音波設備的興起
技術創新持續影響眼科超音波市場。可攜式手持設備,例如 Quantel Medical 的 Pocket III 角膜厚度計和 Keeler 的配備 A 型掃描探頭的 4Sight(於 2024 年 5 月上市),因其便攜性、準確性和易用性而日益受到歡迎。同時,3D超音波成像正在成為一種變革性趨勢,提高了診斷準確性,並為臨床決策提供了更全面的可視化效果。
The global ophthalmic ultrasound market is witnessing steady expansion driven by rising eye-related disorders, technological innovation, and the introduction of advanced ocular diagnostic devices. As reported in 2024, the market size reached USD 283.9 million, with projections indicating growth to USD 303.7 million in 2025, and eventually USD 499.6 million by 2032. This reflects a strong CAGR of 7.4% from 2025 to 2032, signaling sustained long-term demand for ophthalmic imaging technologies.
Ophthalmic ultrasound devices support ophthalmologists in visualizing the internal structures of the eye, including the retina, orbit, vitreous, and anterior segment. These imaging tools play a critical role in diagnosing glaucoma, diabetic retinopathy, vitreous hemorrhage, tumors, and trauma-related ocular complications. Rising global cases of hyperopia, cataracts, and glaucoma are boosting the need for accurate diagnostic instruments. For instance, Crystal Vision Ltd. estimated that 30.6% of adults worldwide will suffer from hyperopia by the end of 2025, emphasizing the need for early detection technologies.
North America Leads with 42.40% Market Share in 2024
North America dominated the global market in 2024 with a 42.40% share, generating USD 120.4 million in revenue. The region's leadership is attributed to advanced healthcare infrastructure, widespread clinical adoption of imaging tools, and increased prevalence of various ocular diseases. According to CDC data from 2024, 4.2 million people in the U.S. were living with glaucoma, including 1.5 million individuals with vision-affecting glaucoma. The high disease burden strengthens demand for ophthalmic diagnostic devices across clinical settings. Active participation of companies such as Micro Medical Devices (MMD), Keeler, and NIDEK at medical expos and conferences also contributes to increased product visibility and adoption.
Market Drivers: Growing Burden of Eye Disorders
Global incidences of hyperopia, glaucoma, AMD, and diabetic retinopathy continue to rise, creating an urgent need for ophthalmic ultrasound systems capable of early detection. Hyperopia alone is projected to impact 37.2% of adults in America and 23.1% in Europe by the end of 2025, according to Crystal Vision Ltd. These conditions require precise imaging for both diagnosis and surgical planning, and ophthalmic ultrasound remains a crucial tool toward effective disease management.
Market Restraints: High Costs and Availability of Alternatives
Despite growing demand, the adoption of ophthalmic ultrasound systems is limited by high device costs, which typically range from USD 5,500 to USD 20,000. This restricts availability in lower-income regions and smaller medical establishments. Moreover, advanced imaging alternatives-such as Optical Coherence Tomography (OCT), fundus imaging, and MRI-are increasingly favored by clinicians for their sophisticated diagnostic capabilities. The launch of new OCT devices, such as NIDEK's RS-1 Glaucoma OCT system in June 2024, adds competitive pressure on traditional ultrasound methods.
Opportunities: Healthcare Infrastructure Expansion
Increasing establishment of ophthalmic clinics, eye hospitals, and specialized diagnostic centers worldwide provides new market opportunities. For example, the Gadigal Eye Clinic at Sydney Eye Hospital, launched in October 2024, expanded diagnostic capacity in Australia. Eye-care awareness programs, such as Glaucoma Awareness Week by LVPEI in March 2025, further encourage early screening and bolster demand for diagnostic ultrasound devices.
Technology Trends: Portable & 3D Ultrasound Devices Gain Traction
Technological advancements continue to shape the ophthalmic ultrasound market. Portable and handheld devices-such as Quantel Medical's Pocket III pachymeter launched in May 2024 and Keeler's 4Sight with A-Scan probe-are gaining popularity due to their mobility, accuracy, and ease of use. Meanwhile, 3D ultrasound imaging is emerging as a transformative trend, enhancing diagnostic precision and offering more comprehensive visualization for clinical decision-making.
Competitive Landscape
Major companies in the market include Keeler, HAI Laboratories, Micro Medical Devices (MMD), Lumibird Medical, NIDEK CO., LTD., Sonomed Escalon, and DGH Technology. Expansion strategies and manufacturing upgrades are key competitive factors. A notable development occurred in February 2025, when Keeler opened a new state-of-the-art manufacturing facility in Shanghai, strengthening localized production and supporting rising demand in China.
Segmentation By Product
By Device Type
By Imaging Type
By End-user
By Region